SNS Insider Report Highlights 10.04% CAGR Growth Fueled by Technological Breakthroughs and Rising Global Cancer Burden.Pune, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Tumor Profiling Market Size & Growth ...
The Providence Cancer Center at Alaska Medical Center in Anchorage, part of Renton, Wash.-based Providence, will become the first hospital in Alaska to offer the targeted prostate cancer therapy, ...
Melatonin supplement significantly boosts DNA repair markers, suggesting potential cancer prevention benefits - Anadolu ...
A new assay rapidly detected pancreatic ductal adenocarcinoma and differentiated it from noncancer pancreatic diseases by ...
One in six patients in phase II oncology clinical trials received a treatment that was eventually approved by the FDA, ...
Early diagnosis of lung cancer is a critical priority in clinical practice. It may help reduce the rate of lung-cancer-related mortality, extend disease-free survival, and allow patients to live ...
Pancreatic cancer kills three in four people within the first year. But new research is offering hope to people in years to ...
Early diagnosis of lung cancer is a critical priority in clinical practice. It may help reduce the rate of ...
MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf invariant natural killer T (iNKT) cell therapies, today ...
This new review article highlights the crucial role of GATA6, a transcription factor, in pancreatic ductal adenocarcinoma ...
Scientists at Oregon Health and Science University (OHSU) have developed a new blood test for pancreatic cancer, one of the ...
Feb. 6, 2025 — Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices to spot the disease even ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results